Gene · 50802
IGK: immunoglobulin kappa locus
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. IGK: immunoglobulin kappa locus. Genes, record 50802. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/50802
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,433
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IGK papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 27 | 2025 |
| ZIASC000550 | Lymphoma Disease Discovery and Definition | 19 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 16 | 2025 |
| ZIABC011070 | Hematopathology Diagnosis | 14 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 13 | 2025 |
| UM1AI144462 | Consortium for HIV/AIDS Vaccine Development | 13 | 2025 |
| ZIEBC011241 | Hematopathology Fellowship | 11 | 2025 |
| P01AI100148 | Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies | 10 | 2025 |
| ZICBC011079 | Molecular Diagnostics Core Laboratory | 10 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 9 | 2025 |
1 to 10 of 1,433Source NIH's project files
See all 1,433 nih grantsPapers1,894
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retained epcoritamab activity despite routine CD20 assay negativity approximately one terminal half-life after mosunetuzumab in B-cell lymphoma. | J Clin Exp Hematop | 2026 | 42816411 | PubTator, text mining | PubMed |
| Proteomic Profile Differences in Immune-Related Diseases in Pediatric Patients Under Five Years Old: Asthma and IgE-Dependent Allergies-A Pilot Study. | Int J Mol Sci | 2026 | 42737666 | PubTator, text mining | PubMed |
| Immune Repertoire Profiling Reveals Distinct Adaptive Immune Signatures of Dampness ZHENG Across Psoriasis, Rheumatoid Arthritis and Ulcerative Colitis. | Cell Prolif | 2026 | 42470161 | PubTator, text mining | PubMed |
| Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus. | Antiviral Res | 2026 | 42442613 | PubTator, text mining | PubMed |
| Primary breast follicular lymphoma without a BCL2 rearrangement: insights into extranodal lymphoma biology. | Blood Res | 2026 | 42348104 | PubTator, text mining | PubMed |
| Annotation of bat IG H/L/K loci and analysis of the characteristics of bat BCR-CDR3 repertoires. | Front Immunol | 2026 | 42245652 | PubTator, text mining | PubMed |
| Characteristics of immunoglobulin gene rearrangements in vietnamese newly diagnosed multiple myeloma patients. | Leuk Res Rep | 2026 | 42222745 | PubTator, text mining | PubMed |
| Precision Medicine in a Patient With Multiple Myeloma Presenting With t(2;11) and CCND1 Overexpression. | EJHaem | 2026 | 42078475 | PubTator, text mining | PubMed |
| B-Cell Differentiation of Human Hematopoietic Progenitors Is Efficiently Supported by Wharton Jelly-Derived Mesenchymal Stem Cells. | Eur J Immunol | 2026 | 41934200 | PubTator, text mining | PubMed |
| KREPA6 functions in RNA editing catalytic complex structural organization and gRNA utilization in Trypanosoma brucei. | Nucleic Acids Res | 2026 | 41914499 | PubTator, text mining | PubMed |
1 to 10 of 1,894
See all 1,894 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/50802
GET https://conductscience.org/api/genes/v1/50802/grants?page=2